Retweets Not = Endorsements | Not SEBI Registered | No Onus about Stocks I Mention OR to Report Buys & Sells | Please Do UR own Research & Due Diligence
Nothing I say should be taken as recommendation! Don’t intend to become Twitter Guru! If you act on my tweet, RISK is yours. Assume bias & vested interest in everything I write about. I am here only due to the urge of saying something (sometimes asking something as well😊) or 1/n
@Vedansh_Ag@HiteshRandhawa Not here to sell something on X and neither here for glory or recognition and more importantly not here for pretence or to make fool of others and most importantly myself!!!
The screenshot is the fact!!!
Now get lost and wander off into oblivion!!!
@Vedansh_Ag@HiteshRandhawa Did you delete those tweets 'coz it would be evident what a dumb fool you are? OR did you delete 'coz folks here would realize that you are nothing but another wannabe????
I talk and invest basis facts and data!!!
Not here to sell something on X and neither here for glory or
@LearningEleven ACME Solar is an interesting one too PAT can go 3-4x in next 2-3 years!
PAT uptick should start from Q1FY27 if not Q4FY26 onwards.
Not a Solar Cell and Module player and IPP/FDRE/BESS story therefore may get attention due to theme based narrative too!
@r_laroia Yes, mkts are made to go up only, and only when it goes down there is manipulation!!
Signs were there!!
Anybody with decent experience in mkts can see your recent timeline and gauge your desperation and positions being stuck!!
What a disgrace and disservice to your followers!!
CANCER HAS BEEN CURED
Ivermectin & Fenbendazole cure cancer.
Pass it on.
BREAKING NEWS: First-in-the-World Ivermectin, Mebendazole and Fenbendazole Protocol in Cancer has been peer-reviewed and published on Sep.19, 2024!
The future of Cancer Treatment starts NOW.
My thanks to lead authors Ilyes Baghli and Pierrick Martinez for their incredible inspired work, FLCCC’s Dr.Paul Marik for his extensive work on repurposed drugs and every co-author who worked hard to bring this paper to life.
I hope that this peer-reviewed paper lays the groundwork for a brand new future for Cancer Treatment.
Many of you know that I have been helping thousands of Cancer patients with high dose Ivermectin, Mebendazole, and Fenbendazole
@InvesysCapital Silver holding from $28!
Gold since $1900-2000!
DSP Miners Gold Fund from Rs. 19!
Have just started trimming the first 2 to book some profits.
https://t.co/mPLdBncvBJ
#SYRMASGS seems to be playing the long term sustainable game.
Promoter pedigree seems to be top notch.
PCB venture with Shinhyup Electronics if takes off then can be a game changer!
Mgmt. seems to be balanced in their guidance and are walking the talk.
#Syrma can surprise in next 2-3 yrs.
Business and Earnings Quality is improving de-risking it's business model (unlike Dixon, Amber and PGEL's of the world).
Everything they are doing seems to be a very well thought out strategy.
Putting below few links and screenshots that I used in my analysis and discussions, etc.,
Esimates I have posted are my view and are just rough back of the envelope calculations to get a directional view and not a detailed work, therefore please ignore it and come up with your own estimates.
1. Q1FY26 (July 24, 2025) Guidance Summary https://t.co/m6GwzkLJfO
2. AI generated information links to get overview on certain areas given below.
Syrma SGS: BUSINESS ANALYSIS REPORTS
Comprehensive Report on Syrma SGS Technology Limited Promoters
https://t.co/xhgWQZDV9x
Syrma SGS Acquisition History and Competitive Analysis
https://t.co/JQH8FD2WV1
Syrma SGS Technology Business Analysis
https://t.co/MU4k5TT1Vq
Syrma SGS vs Global EMS Leaders Evolution Journey
https://t.co/fsMzDqGFx4
Asian Electronics Firms' India Strategy
https://t.co/H10RKjGZUL
Shinhyup Electronics Business Risk Analysis
https://t.co/kBElECEnYi
Korea Circuit Business Risk Analysis (Amber's JV Partner)
https://t.co/Y5WJmfo2k8
Rexxam Business Risk Assessment (Dixon's JV Partner)
https://t.co/2u2tcTbWA3
P.S.
1. Take everything mentioned in the post and all the data and analysis with bucket of salt as AI generated (not all information maybe correct, objective is to get high level view of the business)
2. Invested, Assume Bias & Vested Interest
3. Read disclaimer/disclosure in Pinned message on the profile
4. Not a recommendation to Buy/Sell (ignore the investment or buy/sell thesis in the AI generated summary; it is not my view and AI generated automatically)
5. Do your own due diligence and consult your financial advisor
#Syrma
So basically at 12 noon the presenter says 15 mins break and it's almost 12.40.
As per schedule circulated too next session should have started by 12.30 but were playing Housie till now & then @ias_summit would say running behind & will curtail presenter sessions 😏
#ias2025
Totally agree!!
Getting similar feedback from few people present physically as well in the summit that more tamasha and less substance!!!
#ias2025@ias_summit@MashraniVivek
Totally agree!!
Getting similar feedback from few people present physically as well in the summit that more tamasha and less substance!!!
#ias2025@ias_summit@MashraniVivek
This year's #ias2025 online version by @ias_summit has to be one of the worst ones!
Poor Day 1.
Day 2 : Such poor video and audio quality, can't make out anything!
Plus as per schedule should have started at 10 AM but again Dance tamasha etc, & starts at 10.30 AM.
@MashraniVivek